Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

NCT03478904 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Stopped Study drug is now commercially available in tablet format

Conditions

Prostate Cancer

Interventions

DRUG: Enzalutamide Liquid
DRUG: Enzalutamide Capsule

Sponsor

National Cancer Institute (NCI)